Paul Jeng
Stock Analyst at Guggenheim
(2.87)
# 1,941
Out of 5,014 analysts
4
Total ratings
100%
Success rate
26.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paul Jeng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Assumes: Neutral | n/a | $33.76 | - | 1 | Sep 18, 2025 | |
| IMTX Immatics | Initiates: Buy | $16 | $10.90 | +46.79% | 1 | Sep 18, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $5 | $1.40 | +257.14% | 1 | Sep 18, 2025 | |
| IDYA IDEAYA Biosciences | Initiates: Buy | $50 | $26.79 | +86.64% | 1 | Sep 18, 2025 |
Immunocore Holdings
Sep 18, 2025
Assumes: Neutral
Price Target: n/a
Current: $33.76
Upside: -
Immatics
Sep 18, 2025
Initiates: Buy
Price Target: $16
Current: $10.90
Upside: +46.79%
Context Therapeutics
Sep 18, 2025
Initiates: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
IDEAYA Biosciences
Sep 18, 2025
Initiates: Buy
Price Target: $50
Current: $26.79
Upside: +86.64%